We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUBY
1751
DELISTED
Rubius Therapeutics, Inc
RUBY
– –
-13,204
Closed -$239K
CEA
1752
DELISTED
China Eastern Airlines
CEA
– –
-744
Closed -$26K
BNFT
1753
DELISTED
Benefitfocus, Inc.
BNFT
– –
-163,165
Closed -$8.08M
TCDA
1754
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-2,591
Closed -$100K
PRTY
1755
DELISTED
Party City Holdco Inc.
PRTY
– –
-12,865
Closed -$102K
SPNE
1756
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-6,043
Closed -$91K
SWCH
1757
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-163,278
Closed -$1.68M
SECO
1758
DELISTED
Secoo Holding Limited ADR
SECO
– –
-258
Closed -$23K
AERI
1759
DELISTED
Aerie Pharmaceuticals
AERI
– –
-95,578
Closed -$4.54M
CYBE
1760
DELISTED
Cyberoptics Corp
CYBE
– –
-4,302
Closed -$74K
USWS
1761
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
– –
-387
Closed -$65K
CCXI
1762
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-16,938
Closed -$235K
CVET
1763
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-38,251
Closed -$1.22M
ABTX
1764
DELISTED
Allegiance Bancshares
ABTX
– –
-7,526
Closed -$254K
POLY
1765
DELISTED
Plantronics, Inc.
POLY
– –
-6,484
Closed -$299K
EPZM
1766
DELISTED
Epizyme, Inc
EPZM
– –
-18,942
Closed -$235K
WBT
1767
DELISTED
Welbilt, Inc.
WBT
– –
-51,792
Closed -$848K
PSB
1768
DELISTED
PS Business Parks, Inc.
PSB
– –
-100
Closed -$16K
PLAN
1769
DELISTED
Anaplan, Inc.
PLAN
– –
-190
Closed -$7K
ENIA
1770
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
– –
-2,249
Closed -$20K
ANAT
1771
DELISTED
American National Group, Inc. Common Stock
ANAT
– –
-3,995
Closed -$483K
MIME
1772
DELISTED
Mimecast Limited
MIME
– –
-11,282
Closed -$534K
XENT
1773
DELISTED
Intersect ENT, Inc
XENT
– –
-557
Closed -$18K
EVFM
1774
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
– –
-6
Closed –
HMHC
1775
DELISTED
Houghton Mifflin Harcourt Company
HMHC
– –
-15,463
Closed -$112K
69 70
71
72 73

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.